Rankings
▼
Calendar
EOLS FY 2015 Earnings — Evolus, Inc. Revenue & Financial Results | Market Cap Arena
EOLS
Evolus, Inc.
$338M
FY 2015 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$0
Gross Profit
-$416,000
Operating Income
-$31M
Net Income
-$31M
EPS (Diluted)
$-1.67
Cash Flow
Operating Cash Flow
-$36M
Free Cash Flow
-$36M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$81M
Total Liabilities
$69M
Stockholders' Equity
$12M
Cash & Equivalents
$4M
← Q1 2016
All Quarters